Meeting NewsVideo

VIDEO: Quantiferon testing in a lupus clinical trial

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Niti Goel, MD, discussed a post hoc analysis evaluating the utility of the QuantiFERON-Tuberculosis GOLD test (QFT) and repeat testing for indeterminate results in the screening of patients in a systematic lupus erythematosus clinical trial. According to Goel, repeat indeterminate QFT results for tuberculosis were infrequent.

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Niti Goel, MD, discussed a post hoc analysis evaluating the utility of the QuantiFERON-Tuberculosis GOLD test (QFT) and repeat testing for indeterminate results in the screening of patients in a systematic lupus erythematosus clinical trial. According to Goel, repeat indeterminate QFT results for tuberculosis were infrequent.

    See more from American College of Rheumatology Annual Meeting